MDT
Medtronic plc
NYSE · Healthcare · Medical - Devices · IE
$94.28
+1.27%Jun 12, 2026, 15:00 UTC
Medtronic completed its acquisition of Scientia Vascular for $550 million.
Source:Jun 9, 2026, 17:41 UTC
Medtronic plc announced its intention to acquire SPR Therapeutics, Inc. for approximately $650 million in cash.
Source:Jun 8, 2026, 16:05 UTC
Medtronic received FDA 510(k) clearance for its Nellcor pulse oximetry system with Nell-EQ intelligent processor.
Jun 8, 2026, 11:41 UTC
The U.S. Food and Drug Administration approved Medtronic's Hugo robotic-assisted surgery platform for urologic procedures in December 2025.
Source:Jun 5, 2026, 13:39 UTC
Medtronic launched its Stealth AXiS robotic system for spine, cranial, and ENT surgeries in April 2025, with rollout in Kentucky, Virginia, West Virginia, and California.
Source:Jun 5, 2026, 01:56 UTC
Medtronic reported fiscal fourth-quarter adjusted earnings of $1.55 per share and revenue of $9.8 billion, exceeding analyst expectations.
Jun 4, 2026, 10:34 UTC
CereVasc, Inc. completed an $85 million Series C financing led by Piper Sandler Merchant Banking with participation from Johnson & Johnson Innovation – JJDC, Inc., Medtronic, and existing investors.
Source:Jun 3, 2026, 11:05 UTC
Medtronic submitted 510(k) filings to expand the Hugo robotic-assisted surgery system into general and gynecologic specialties in the United States.
Source:Jun 3, 2026, 00:00 UTC
Medtronic plc reported Q4 fiscal 2026 financial results with revenue of $9.807 billion and GAAP diluted EPS of $0.96.
← PreviousPage 2